Fractional non-ablative and ablative: Why the world’s first 3 wavelengths make sense for optimal skin correction

This webinar explores the scientific rationale behind Tribrid technology, which integrates the 1470 nm, 1927 nm, and 2940 nm wavelengths to address multiple layers of cutaneous pathology within a single, controlled treatment. We will review how each wavelength interacts with water and tissue at different depths—1927 nm targeting the epidermis, 1470 nm reaching the deeper dermal compartment, and 2940 nm providing precise fractional ablation—and why this combination supports a more comprehensive approach to pigmentation, textural irregularities, and dermal remodelling.

Evidence on the coordinated thermal zones created by these wavelengths will be discussed, including advantages in treatment efficiency, structural collagen change, and the potential for more predictable clinical improvement compared with single-modality or sequential treatments. Safety considerations, endpoint recognition, and parameter selection will also be covered to support consistent, reproducible outcomes in diverse patient presentations.